Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Dattilo

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Heart Rhythm|December 7, 2025
Effectiveness and safety of upgrading to conduction system pacing compared with biventricular pacing in patients with pacing-induced cardiomyopathy: Results of a propensity score-matched analysis from a multicenter registryPietro Palmisano, Gabriele Dell'Era, Matteo Ziacchi, et al.
ESC Heart Failure|June 15, 2022
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEFValeria Visco, Ilaria Radano, Alfonso Campanile, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closurePasquale Crea, Giampiero Vizzari, Claudia Rubino, et al.
Journal of Electrocardiology|August 14, 2022
Non-conducted premature atrial complexes: A new independent predictor of atrial fibrillation in cryptogenic strokeGiampaolo Vetta, Antonio Parlavecchio, Rodolfo Caminiti, et al.
ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 18, 2025
Subclinical left ventricular dysfunction assessed by global longitudinal strain correlates with mild cognitive impairment in hypertensive patientsGermano Junior Ferruzzi, Alfonso Campanile, Valeria Visco, et al.
Journal of Cardiovascular Electrophysiology|December 15, 2023
Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patientsLorenzo Pistelli, Giampaolo Vetta, Antonio Parlavecchio, et al.
Cardiovascular Diabetology|November 23, 2024
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is betterFrancesco Loria, Pasquale Mone, Antonella Rispoli, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Heart Rhythm|December 7, 2025
Effectiveness and safety of upgrading to conduction system pacing compared with biventricular pacing in patients with pacing-induced cardiomyopathy: Results of a propensity score-matched analysis from a multicenter registryPietro Palmisano, Gabriele Dell'Era, Matteo Ziacchi, et al.
ESC Heart Failure|June 15, 2022
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEFValeria Visco, Ilaria Radano, Alfonso Campanile, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closurePasquale Crea, Giampiero Vizzari, Claudia Rubino, et al.
Journal of Electrocardiology|August 14, 2022
Non-conducted premature atrial complexes: A new independent predictor of atrial fibrillation in cryptogenic strokeGiampaolo Vetta, Antonio Parlavecchio, Rodolfo Caminiti, et al.
ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 18, 2025
Subclinical left ventricular dysfunction assessed by global longitudinal strain correlates with mild cognitive impairment in hypertensive patientsGermano Junior Ferruzzi, Alfonso Campanile, Valeria Visco, et al.
Journal of Cardiovascular Electrophysiology|December 15, 2023
Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patientsLorenzo Pistelli, Giampaolo Vetta, Antonio Parlavecchio, et al.
Cardiovascular Diabetology|November 23, 2024
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is betterFrancesco Loria, Pasquale Mone, Antonella Rispoli, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Pageof 13